229 related articles for article (PubMed ID: 36931102)
21. The tumor microenvironment promotes cancer progression and cell migration.
Salvatore V; Teti G; Focaroli S; Mazzotti MC; Mazzotti A; Falconi M
Oncotarget; 2017 Feb; 8(6):9608-9616. PubMed ID: 28030810
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment.
Ségaliny AI; Mohamadi A; Dizier B; Lokajczyk A; Brion R; Lanel R; Amiaud J; Charrier C; Boisson-Vidal C; Heymann D
Int J Cancer; 2015 Jul; 137(1):73-85. PubMed ID: 25471534
[TBL] [Abstract][Full Text] [Related]
23. Enhancing osteosarcoma therapy through aluminium hydroxide nanosheets-enabled macrophage modulation.
Cheng M; Jiang Y; Wang Y; Wu Y; Zhu Y
Int J Pharm; 2024 Jan; 649():123640. PubMed ID: 38043749
[TBL] [Abstract][Full Text] [Related]
24. Morphological and Mechanical Properties of Osteosarcoma Microenvironment Cells Explored by Atomic Force Microscopy.
Wang X; Yang Y; Hu X; Kawazoe N; Yang Y; Chen G
Anal Sci; 2016; 32(11):1177-1182. PubMed ID: 27829622
[TBL] [Abstract][Full Text] [Related]
25. Ca
Ohya S; Kajikuri J; Endo K; Kito H; Elboray EE; Suzuki T
Cancer Sci; 2021 Sep; 112(9):3769-3783. PubMed ID: 34181803
[TBL] [Abstract][Full Text] [Related]
26. TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state.
Mori T; Sato Y; Miyamoto K; Kobayashi T; Shimizu T; Kanagawa H; Katsuyama E; Fujie A; Hao W; Tando T; Iwasaki R; Kawana H; Morioka H; Matsumoto M; Saya H; Toyama Y; Miyamoto T
Oncogene; 2014 Aug; 33(33):4236-41. PubMed ID: 24336323
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells.
Jang YS; Kim TW; Ryu JS; Kong HJ; Jang SH; Nam GH; Kim JH; Jeon S
PLoS One; 2023; 18(2):e0277285. PubMed ID: 36757936
[TBL] [Abstract][Full Text] [Related]
28. Mechanomimetic 3D Scaffolds as a Humanized In Vitro Model for Ovarian Cancer.
Paradiso F; Lenna S; Gazze SA; Garcia Parra J; Murphy K; Margarit L; Gonzalez D; Francis L; Taraballi F
Cells; 2022 Feb; 11(5):. PubMed ID: 35269446
[TBL] [Abstract][Full Text] [Related]
29. The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response.
Cascini C; Chiodoni C
Cells; 2021 Jul; 10(7):. PubMed ID: 34359840
[TBL] [Abstract][Full Text] [Related]
30. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
[TBL] [Abstract][Full Text] [Related]
31. Mechanical Property of Hydrogels and the Presence of Adipose Stem Cells in Tumor Stroma Affect Spheroid Formation in the 3D Osteosarcoma Model.
Kundu B; Bastos ARF; Brancato V; Cerqueira MT; Oliveira JM; Correlo VM; Reis RL; Kundu SC
ACS Appl Mater Interfaces; 2019 Apr; 11(16):14548-14559. PubMed ID: 30943004
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis.
Mooring M; Fowl BH; Lum SZC; Liu Y; Yao K; Softic S; Kirchner R; Bernstein A; Singhi AD; Jay DG; Kahn CR; Camargo FD; Yimlamai D
Hepatology; 2020 May; 71(5):1813-1830. PubMed ID: 31505040
[TBL] [Abstract][Full Text] [Related]
33. Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) mediate cell density-dependent proinflammatory responses.
Zhang Q; Han X; Chen J; Xie X; Xu J; Zhao Y; Shen J; Hu L; Xu P; Song H; Zhang L; Zhao B; Wang YJ; Xia Z
J Biol Chem; 2018 Nov; 293(47):18071-18085. PubMed ID: 30315101
[TBL] [Abstract][Full Text] [Related]
34. Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.
Ling HY; Yang Z; Wang PJ; Sun Y; Ju SG; Li J; Fu JX
Chem Biol Interact; 2022 Jan; 352():109779. PubMed ID: 34922904
[TBL] [Abstract][Full Text] [Related]
35. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
[TBL] [Abstract][Full Text] [Related]
36. Identification and Functional Analysis of EPOR
Li Y; Li M; Wei R; Wu J
J Immunol Res; 2020; 2020():9374240. PubMed ID: 32908942
[TBL] [Abstract][Full Text] [Related]
37. STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment.
Jesser EA; Brady NJ; Huggins DN; Witschen PM; O'Connor CH; Schwertfeger KL
Breast Cancer Res; 2021 Nov; 23(1):104. PubMed ID: 34743736
[TBL] [Abstract][Full Text] [Related]
38. Soft Substrate Promotes Osteosarcoma Cell Self-Renewal, Differentiation, and Drug Resistance Through miR-29b and Its Target Protein Spin 1.
Li S; Bai H; Chen X; Gong S; Xiao J; Li D; Li L; Jiang Y; Li T; Qin X; Yang H; Wu C; You F; Liu Y
ACS Biomater Sci Eng; 2020 Oct; 6(10):5588-5598. PubMed ID: 33320589
[TBL] [Abstract][Full Text] [Related]
39. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
[TBL] [Abstract][Full Text] [Related]
40. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
Zhang C; Ma K; Li WY
Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
